Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to -$4.0 million.

  • Traws Pharma's Cash from Operations rose 6504.88% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.5 million, marking a year-over-year increase of 3550.13%. This contributed to the annual value of -$29.8 million for FY2024, which is 6613.87% down from last year.
  • According to the latest figures from Q3 2025, Traws Pharma's Cash from Operations is -$4.0 million, which was up 6504.88% from -$6.0 million recorded in Q2 2025.
  • Over the past 5 years, Traws Pharma's Cash from Operations peaked at -$3.9 million during Q4 2022, and registered a low of -$11.5 million during Q3 2024.
  • For the 5-year period, Traws Pharma's Cash from Operations averaged around -$5.2 million, with its median value being -$4.4 million (2024).
  • Per our database at Business Quant, Traws Pharma's Cash from Operations crashed by 15679.12% in 2024 and then soared by 6504.88% in 2025.
  • Over the past 5 years, Traws Pharma's Cash from Operations (Quarter) stood at -$4.3 million in 2021, then rose by 8.93% to -$3.9 million in 2022, then fell by 14.06% to -$4.4 million in 2023, then increased by 8.8% to -$4.0 million in 2024, then grew by 0.72% to -$4.0 million in 2025.
  • Its last three reported values are -$4.0 million in Q3 2025, -$6.0 million for Q2 2025, and -$5.4 million during Q1 2025.